CDK2 and glioblastoma: In addition, as it was determined by Real-Time qPCR, LY294002 and Nrf2 ablation also suppressed CDK2, CDK6, and Cyclin D1 expressions to block mitosis in the M2-CM-treated GBM cells (Figures 6(d) and 6(e)).